Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitors
Felix Scheuplein(Blueprint Medicines (United States)), James R. Bischoff(Spanish National Cancer Research Centre)
Cited by 4
Related Papers
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
|The EMBO Journal|1998|1.2k